<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Polymorphisms in Turkish population &#187; Medical</title>
	<atom:link href="http://polymorphisms.info/tag/medical/feed" rel="self" type="application/rss+xml" />
	<link>http://polymorphisms.info</link>
	<description></description>
	<lastBuildDate>Thu, 19 May 2011 20:57:51 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>The relationship between paraoxanase gene Leu-Met (55) and Gln-Arg (192) polymorphisms and coronary artery disease</title>
		<link>http://polymorphisms.info/gene-polymorphisms/paraoxonase-gene-polymorphisms/the-relationship-between-paraoxanase-gene-leu-met-55-and-gln-arg-192-polymorphisms-and-coronary-artery-disease-2.html</link>
		<comments>http://polymorphisms.info/gene-polymorphisms/paraoxonase-gene-polymorphisms/the-relationship-between-paraoxanase-gene-leu-met-55-and-gln-arg-192-polymorphisms-and-coronary-artery-disease-2.html#comments</comments>
		<pubDate>Thu, 25 Feb 2010 20:06:25 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Paraoxonase]]></category>
		<category><![CDATA[Arg]]></category>
		<category><![CDATA[arginine]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[Celal]]></category>
		<category><![CDATA[electrocardiogram]]></category>
		<category><![CDATA[esterase]]></category>
		<category><![CDATA[Faculty]]></category>
		<category><![CDATA[HDL]]></category>
		<category><![CDATA[LDL]]></category>
		<category><![CDATA[Leu]]></category>
		<category><![CDATA[lipoprotein]]></category>
		<category><![CDATA[Manisa]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Medicine]]></category>
		<category><![CDATA[methionine]]></category>
		<category><![CDATA[paraoxanase]]></category>
		<category><![CDATA[paraoxonase]]></category>
		<category><![CDATA[patient]]></category>
		<category><![CDATA[polymorphism]]></category>
		<category><![CDATA[PON]]></category>
		<category><![CDATA[restriction]]></category>
		<category><![CDATA[risk]]></category>
		<category><![CDATA[susceptibility]]></category>
		<category><![CDATA[Turkey]]></category>
		<category><![CDATA[University]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=308</guid>
		<description><![CDATA[Turk Kardiyol Dern Ars. 2009 Oct;37(7):473-8.
Taşkiran P, Cam SF, Sekuri C, Tüzün N, Alioğlu E, Altintaş N, Berdeli A.
Department of Medical Biology and Genetics, Medicine Faculty of Celal Bayar University, Manisa, Turkey.
OBJECTIVES: Paraoxonase (PON1) is a high-density lipoprotein (HDL)-associated esterase that hydrolyses lipoperoxides. PON1 serves as a protective factor against oxidative modification of LDL, suggesting [...]]]></description>
			<content:encoded><![CDATA[<p>Turk Kardiyol Dern Ars. 2009 Oct;37(7):473-8.</p>
<p>Taşkiran P, Cam SF, Sekuri C, Tüzün N, Alioğlu E, Altintaş N, Berdeli A.</p>
<p>Department of Medical Biology and Genetics, Medicine Faculty of Celal Bayar University, Manisa, Turkey.</p>
<p>OBJECTIVES: Paraoxonase (PON1) is a high-density lipoprotein (HDL)-associated esterase that hydrolyses lipoperoxides. PON1 serves as a protective factor against oxidative modification of LDL, suggesting that it may play an important role in the prevention of atherosclerotic process. Research has focused on two polymorphisms: leucine (L allele) to methionine (M allele) substitution at codon 55, and glutamine (A allele) to arginine (B allele) substitution at codon 192. STUDY DESIGN: We examined amino acid changes at codon 55 and 192 in the PON1 gene by polymerase chain reaction and using restriction enzymes in 120 patients (92 men, 28 women; mean age 48.2+/-4.3 years) with premature coronary artery disease (CAD) and in 102 healthy subjects (80 men, 22 women; mean age 46.8+/-5.2 years) with no history of CAD and a normal electrocardiogram. RESULTS: Distribution of genotypes in the patient and control groups at codon 55 were 6.7% and 4.9% for MM, 46.7% and 29.4% for LM, 46.7% and 65.7% for LL, respectively. The frequency of genotypes at codon 192 were as follows: 4.2% and 2% for RR, 40% and 35.3% for QR, and 55.8% and 62.8% for QQ, respectively. While the frequency of PON1 55M allele was higher in the CAD group (0.3 vs. 0.2), PON1 192R allele frequency did not differ (p&gt;0.05). There was a significant relationship between the PON1 M/L55 polymorphism and CAD (p=0.017), whereas the R/Q192 polymorphism was not associated with CAD (p=0.445). CONCLUSION: These data suggest that the PON1 M/L55 polymorphism shows a significant relationship with CAD and the Q/R192 polymorphism is not a major risk factor causing susceptibility to CAD in our population.</p>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/gene-polymorphisms/paraoxonase-gene-polymorphisms/the-relationship-between-paraoxanase-gene-leu-met-55-and-gln-arg-192-polymorphisms-and-coronary-artery-disease-2.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>677C&gt;T and 1298A&gt;C Polymorphisms of Methylenetetrahydropholate Reductase Gene and Biochemical Parameters in Turkish Population with Spina Bifida Occulta.</title>
		<link>http://polymorphisms.info/gene-polymorphisms/methylenetetrahydropholate-reductase/677ct-and-1298ac-polymorphisms-of-methylenetetrahydropholate-reductase-gene-and-biochemical-parameters-in-turkish-population-with-spina-bifida-occulta.html</link>
		<comments>http://polymorphisms.info/gene-polymorphisms/methylenetetrahydropholate-reductase/677ct-and-1298ac-polymorphisms-of-methylenetetrahydropholate-reductase-gene-and-biochemical-parameters-in-turkish-population-with-spina-bifida-occulta.html#comments</comments>
		<pubDate>Fri, 05 Feb 2010 20:40:10 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Methylenetetrahydropholate Reductase]]></category>
		<category><![CDATA[Aslan]]></category>
		<category><![CDATA[Biochemical]]></category>
		<category><![CDATA[Buyukbas]]></category>
		<category><![CDATA[C MTHFR]]></category>
		<category><![CDATA[disease]]></category>
		<category><![CDATA[erdogan]]></category>
		<category><![CDATA[Faculty]]></category>
		<category><![CDATA[folate]]></category>
		<category><![CDATA[frequency]]></category>
		<category><![CDATA[gene]]></category>
		<category><![CDATA[Genetics]]></category>
		<category><![CDATA[genotype]]></category>
		<category><![CDATA[homocysteine]]></category>
		<category><![CDATA[homozygosity]]></category>
		<category><![CDATA[M. Selcuk]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Medicine]]></category>
		<category><![CDATA[Meram]]></category>
		<category><![CDATA[Methylenetetrahydropholate]]></category>
		<category><![CDATA[Neurosurg]]></category>
		<category><![CDATA[polymorphism]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[serum]]></category>
		<category><![CDATA[Solak]]></category>
		<category><![CDATA[Turk]]></category>
		<category><![CDATA[Turkey]]></category>
		<category><![CDATA[University]]></category>
		<category><![CDATA[vitamin]]></category>
		<category><![CDATA[Yildiz]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=296</guid>
		<description><![CDATA[Turk Neurosurg. 2010 Jan;20(1):9-15.
Eser B, Cosar M, Eser O, Erdogan MO, Aslan A, Yildiz H, Boyaci G, Buyukbas S, Solak M.
Selcuk University, Meram Faculty of Medicine, Department of Medical Genetics, Konya, Turkey.

AIM: This study aimed to investigate the 677C &#62; T and 1298A &#62; C MTHFR gene polymorphisms and their metabolic effects on the levels [...]]]></description>
			<content:encoded><![CDATA[<p>Turk Neurosurg. 2010 Jan;20(1):9-15.</p>
<p>Eser B, Cosar M, Eser O, Erdogan MO, Aslan A, Yildiz H, Boyaci G, Buyukbas S, Solak M.</p>
<p>Selcuk University, Meram Faculty of Medicine, Department of Medical Genetics, Konya, Turkey.</p>
<div>
<p>AIM: This study aimed to investigate the 677C &gt; T and 1298A &gt; C MTHFR gene polymorphisms and their metabolic effects on the levels of folate, vitamin B12 and homocysteine in the serum of Turkish spina bifida occulta (SBO) patients and healthy individuals in disease. MATERIAL and METHODS: A case-control study was performed to detect 677C &gt; T and 1298A &gt; C MTHFR gene polymorphisms in 39 SBO patients and 34 healthy individuals. The folate, vitamin B12 and homocysteine concentrations in the serum of SBO and healthy individuals were evaluated and compared with MTHFR gene polymorphisms. RESULTS: 677 CC/CT/TT MTHFR genotype frequency differences between the SBO patients and controls were not significant (x(2)=3.325, P=0.068; x(2)=1.479, P=0.224; x(2)=0.275, P=0.600; respectively). 1298A &gt; C MTHFR genotype frequency differences between the SBO patients and controls were significant (x(2)=8.477, P=0.004). The frequencies of the Aand C alleles of the 1298A &gt; C polymorphism did not differ in a statistically significant manner between the groups (x(2)=0.576, P=0.448). The biochemical parameters were not significantly different between SBO patients and healthy individuals (P &gt; 0.05). CONCLUSION: The 677C &gt; T and 1298A &gt; C polymorphisms of the MTHFR gene cannot be regarded as major risk factors for SBO in the Turkish patients 677TT homozygosity may affect the metabolism of homocysteine.</p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/gene-polymorphisms/methylenetetrahydropholate-reductase/677ct-and-1298ac-polymorphisms-of-methylenetetrahydropholate-reductase-gene-and-biochemical-parameters-in-turkish-population-with-spina-bifida-occulta.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The relationship between paraoxanase gene Leu-Met (55) and Gln-Arg (192) polymorphisms and coronary artery disease.]</title>
		<link>http://polymorphisms.info/paraoxanase-gene/the-relationship-between-paraoxanase-gene-leu-met-55-and-gln-arg-192-polymorphisms-and-coronary-artery-disease.html</link>
		<comments>http://polymorphisms.info/paraoxanase-gene/the-relationship-between-paraoxanase-gene-leu-met-55-and-gln-arg-192-polymorphisms-and-coronary-artery-disease.html#comments</comments>
		<pubDate>Wed, 03 Feb 2010 14:47:57 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Paraoxanase gene]]></category>
		<category><![CDATA[allele frequency]]></category>
		<category><![CDATA[amino acid change]]></category>
		<category><![CDATA[Arch]]></category>
		<category><![CDATA[Berdeli]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[control group]]></category>
		<category><![CDATA[control groups]]></category>
		<category><![CDATA[Department]]></category>
		<category><![CDATA[DESIGN]]></category>
		<category><![CDATA[Distribution]]></category>
		<category><![CDATA[enzymes]]></category>
		<category><![CDATA[genet]]></category>
		<category><![CDATA[genotype]]></category>
		<category><![CDATA[Genotypes]]></category>
		<category><![CDATA[Gln]]></category>
		<category><![CDATA[Glu]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[polymerase]]></category>
		<category><![CDATA[polymerase chain reaction]]></category>
		<category><![CDATA[polymorphisms]]></category>
		<category><![CDATA[PON]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[protein]]></category>
		<category><![CDATA[restriction]]></category>
		<category><![CDATA[restriction enzymes]]></category>
		<category><![CDATA[risk]]></category>
		<category><![CDATA[risk factor]]></category>
		<category><![CDATA[substitution]]></category>
		<category><![CDATA[susceptibility]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=291</guid>
		<description><![CDATA[Turk Kardiyol Dern Ars. 2009;37(7):473-478.
Taşkıran P, Cam SF, Sekuri C, Tüzün N, Alioğlu E, Altıntaş N, Berdeli A.
Department of Medical Biology and Genetics, Medicine Faculty of Celal Bayar University, Manisa, Turkey.
OBJECTIVES: Paraoxonase (PON1) is a high-density lipoprotein (HDL)-associated esterase that hydrolyses lipoperoxides. PON1 serves as a protective factor against oxidative modification of LDL, suggesting that [...]]]></description>
			<content:encoded><![CDATA[<p>Turk Kardiyol Dern Ars. 2009;37(7):473-478.</p>
<p>Taşkıran P, Cam SF, Sekuri C, Tüzün N, Alioğlu E, Altıntaş N, Berdeli A.</p>
<p>Department of Medical Biology and Genetics, Medicine Faculty of Celal Bayar University, Manisa, Turkey.</p>
<p>OBJECTIVES: Paraoxonase (PON1) is a high-density lipoprotein (HDL)-associated esterase that hydrolyses lipoperoxides. PON1 serves as a protective factor against oxidative modification of LDL, suggesting that it may play an important role in the prevention of atherosclerotic process. Research has focused on two polymorphisms: leucine (L allele) to methionine (M allele) substitution at codon 55, and glutamine (A allele) to arginine (B allele) substitution at codon 192. STUDY DESIGN: We examined amino acid changes at codon 55 and 192 in the PON1 gene by polymerase chain reaction and using restriction enzymes in 120 patients (92 men, 28 women; mean age 48.2+/-4.3 years) with premature coronary artery disease (CAD) and in 102 healthy subjects (80 men, 22 women; mean age 46.8+/-5.2 years) with no history of CAD and a normal electrocardiogram. RESULTS: Distribution of genotypes in the patient and control groups at codon 55 were 6.7% and 4.9% for MM, 46.7% and 29.4% for LM, 46.7% and 65.7% for LL, respectively. The frequency of genotypes at codon 192 were as follows: 4.2% and 2% for RR, 40% and 35.3% for QR, and 55.8% and 62.8% for QQ, respectively. While the frequency of PON1 55M allele was higher in the CAD group (0.3 vs. 0.2), PON1 192R allele frequency did not differ (p&gt;0.05). There was a significant relationship between the PON1 M/L55 polymorphism and CAD (p=0.017), whereas the R/Q192 polymorphism was not associated with CAD (p=0.445). CONCLUSION: These data suggest that the PON1 M/L55 polymorphism shows a significant relationship with CAD and the Q/R192 polymorphism is not a major risk factor causing susceptibility to CAD in our population.</p>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/paraoxanase-gene/the-relationship-between-paraoxanase-gene-leu-met-55-and-gln-arg-192-polymorphisms-and-coronary-artery-disease.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Association of beta-1 and beta-2 adrenergic receptor gene polymorphisms with myocardial infarction.</title>
		<link>http://polymorphisms.info/gene-polymorphisms/association-of-beta-1-and-beta-2-adrenergic-receptor-gene-polymorphisms-with-myocardial-infarction.html</link>
		<comments>http://polymorphisms.info/gene-polymorphisms/association-of-beta-1-and-beta-2-adrenergic-receptor-gene-polymorphisms-with-myocardial-infarction.html#comments</comments>
		<pubDate>Mon, 24 Aug 2009 20:41:52 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Gene polymorphisms]]></category>
		<category><![CDATA[ADRB]]></category>
		<category><![CDATA[akinyilmaz]]></category>
		<category><![CDATA[Besevler]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[Department]]></category>
		<category><![CDATA[Faculty]]></category>
		<category><![CDATA[Gazi]]></category>
		<category><![CDATA[Glu]]></category>
		<category><![CDATA[Gly]]></category>
		<category><![CDATA[haplotype]]></category>
		<category><![CDATA[homozygote]]></category>
		<category><![CDATA[Kaya MG]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Merdanoglu]]></category>
		<category><![CDATA[noncardiovascular]]></category>
		<category><![CDATA[PCR-RFLP]]></category>
		<category><![CDATA[polymorphism]]></category>
		<category><![CDATA[receptor]]></category>
		<category><![CDATA[University]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=246</guid>
		<description><![CDATA[Yilmaz A, Kaya MG, Merdanoglu U, Ergun MA, Cengel A, Menevse S.
Department of Medical Biology and Genetics, Faculty of Medicine, Gazi University, Besevler, Ankara, 06510, Turkey. akinyilmaz@gazi.edu.tr
Both beta(1)- and beta2-adrenergic receptors (beta(1)- and beta(2)-AR) have important roles in heart function mainly in response to catecholamines. Some specific polymorphisms in the beta(1)- and beta(2)-AR genes, named [...]]]></description>
			<content:encoded><![CDATA[<div class="authors"><!--AuthorList--><strong>Yilmaz A</strong>, <strong>Kaya MG</strong>, <strong>Merdanoglu U</strong>, <strong>Ergun MA</strong>, <strong>Cengel A</strong>, <strong>Menevse S</strong>.</div>
<p class="affiliation">Department of Medical Biology and Genetics, Faculty of Medicine, Gazi University, Besevler, Ankara, 06510, Turkey. akinyilmaz@gazi.edu.tr</p>
<p class="abstract">Both beta(1)- and beta2-adrenergic receptors (beta(1)- and beta(2)-AR) have important roles in heart function mainly in response to catecholamines. Some specific polymorphisms in the beta(1)- and beta(2)-AR genes, named ADRB1 and ADRB2, respectively, have been implicated in several cardiovascular and noncardiovascular phenotypes. In this study, we aimed to investigate the possible relationship between Ser49Gly and Arg389Gly polymorphisms of the ADRB1 and Arg16Gly and Gln27Glu polymorphisms of the ADRB2 gene with ST elevation myocardial infarction (MI) in a Turkish population. One hundred patients with ST elevation MI and 100 healthy control subjects were genotyped using the PCR-RFLP method. Although the Arg389 allele of the ADRB1 gene was associated with an elevated risk of MI, the Glu27 allele of the ADRB2 gene was associated with a decreased risk of MI. Carriers of the ADRB1 Arg389 allele (heterozygotes+homozygotes) had an approximately 3.5-fold increased risk for MI than Gly389 homozygotes (OR=3.59, 95% CI=0.96-13.47, P=0.045). For the ADRB2 Gln27Glu polymorphism, subjects having one or two copies of the Glu27 allele showed a decreased risk of MI compared with Gln27 homozygote subjects (OR=0.48, 95% CI=0.24-0.94, P=0.03). Haplotype analysis of these polymorphisms showed no significant differences between groups. These results suggest that the Arg389Gly and Gln27Glu polymorphisms may be associated with an altered risk of MI in this Turkish population.</p>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/gene-polymorphisms/association-of-beta-1-and-beta-2-adrenergic-receptor-gene-polymorphisms-with-myocardial-infarction.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Novel GDAP1 Mutation in a Turkish Family with CMT2K (CMT2K with Novel GDAP1 Mutation).</title>
		<link>http://polymorphisms.info/cancer-kanser/kategorisiz/novel-gdap1-mutation-in-a-turkish-family-with-cmt2k-cmt2k-with-novel-gdap1-mutation.html</link>
		<comments>http://polymorphisms.info/cancer-kanser/kategorisiz/novel-gdap1-mutation-in-a-turkish-family-with-cmt2k-cmt2k-with-novel-gdap1-mutation.html#comments</comments>
		<pubDate>Wed, 29 Apr 2009 19:42:25 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Kategorilenmemiş]]></category>
		<category><![CDATA[autosomal]]></category>
		<category><![CDATA[axonal]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[Calapoglu]]></category>
		<category><![CDATA[chromosome]]></category>
		<category><![CDATA[CMT]]></category>
		<category><![CDATA[com]]></category>
		<category><![CDATA[Cunur]]></category>
		<category><![CDATA[Demirel]]></category>
		<category><![CDATA[Department]]></category>
		<category><![CDATA[Faculty]]></category>
		<category><![CDATA[gene]]></category>
		<category><![CDATA[generation]]></category>
		<category><![CDATA[Isparta]]></category>
		<category><![CDATA[Marie-Tooth]]></category>
		<category><![CDATA[Med]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Medicine]]></category>
		<category><![CDATA[missense]]></category>
		<category><![CDATA[mutation]]></category>
		<category><![CDATA[mutations]]></category>
		<category><![CDATA[Neuromolecular]]></category>
		<category><![CDATA[nilufersahin]]></category>
		<category><![CDATA[novel]]></category>
		<category><![CDATA[Ozcelik]]></category>
		<category><![CDATA[presence]]></category>
		<category><![CDATA[protein]]></category>
		<category><![CDATA[region]]></category>
		<category><![CDATA[Sahin]]></category>
		<category><![CDATA[splice]]></category>
		<category><![CDATA[Turkey]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=232</guid>
		<description><![CDATA[Neuromolecular Med. 2009 Apr 19.

Sahin-Calapoglu N, Tan M, Soyoz M, Calapoglu M, Ozcelik N.
Department of Medical Biology, Faculty of Medicine, Suleyman Demirel University, 32260 Cunur, Isparta, Turkey, nilufersahin@yahoo.com.
Mutations in the ganglioside-induced differentiation-associated protein 1 gene (GDAP1) cause Charcot-Marie-Tooth type 2 (CMT2), a severe autosomal recessive form of neuropathy associated with axonal phenotypes. It has been [...]]]></description>
			<content:encoded><![CDATA[<p><span title="Neuromolecular medicine."><a href="javascript:AL_get(this, 'jour', 'Neuromolecular Med.');">Neuromolecular Med.</a></span> 2009 Apr 19.</p>
<dd class="abstract">
<div class="authors"><!--AuthorList--><a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Sahin-Calapoglu%20N%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Sahin-Calapoglu N</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Tan%20M%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Tan M</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Soyoz%20M%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Soyoz M</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Calapoglu%20M%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Calapoglu M</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Ozcelik%20N%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Ozcelik N</strong></a>.</div>
<p class="affiliation">Department of Medical Biology, Faculty of Medicine, Suleyman Demirel University, 32260 Cunur, Isparta, Turkey, nilufersahin@yahoo.com.</p>
<p class="abstract">Mutations in the ganglioside-induced differentiation-associated protein 1 gene (GDAP1) cause Charcot-Marie-Tooth type 2 (CMT2), a severe autosomal recessive form of neuropathy associated with axonal phenotypes. It has been screened in this study for the presence of mutations in the coding region of GDAP1, which maps to chromosome 8q21, in a family with CMT2. To date, 29 mutations in the GDAP1 have been reported in patients of different ethnic origins. Here, we report a novel missense mutation (c.836A&gt;G), and two polymorphisms: a silent variant (c.102G&gt;C), and a 5&#8242;-splice site mutation (IVS5+24C&gt;T) in GDPA1 gene identified in a five generation Turkish family with autosomal recessive CMT2.</p>
</dd>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/cancer-kanser/kategorisiz/novel-gdap1-mutation-in-a-turkish-family-with-cmt2k-cmt2k-with-novel-gdap1-mutation.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Genetic polymorphisms of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes in adolescent girls with polycystic ovary syndrome.</title>
		<link>http://polymorphisms.info/capn10/genetic-polymorphisms-of-fshr-cyp17-cyp1a1-capn10-insr-serpine1-genes-in-adolescent-girls-with-polycystic-ovary-syndrome.html</link>
		<comments>http://polymorphisms.info/capn10/genetic-polymorphisms-of-fshr-cyp17-cyp1a1-capn10-insr-serpine1-genes-in-adolescent-girls-with-polycystic-ovary-syndrome.html#comments</comments>
		<pubDate>Wed, 29 Apr 2009 19:39:16 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[CAPN10]]></category>
		<category><![CDATA[SERPINE1]]></category>
		<category><![CDATA[adolescence]]></category>
		<category><![CDATA[Ankara]]></category>
		<category><![CDATA[Besevler]]></category>
		<category><![CDATA[Bideci]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[CAPN]]></category>
		<category><![CDATA[Cinaz]]></category>
		<category><![CDATA[CYP]]></category>
		<category><![CDATA[Department]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[frequency]]></category>
		<category><![CDATA[Gazi]]></category>
		<category><![CDATA[genet]]></category>
		<category><![CDATA[Genetics]]></category>
		<category><![CDATA[INSR]]></category>
		<category><![CDATA[J Assist]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Menevse]]></category>
		<category><![CDATA[nucleotide]]></category>
		<category><![CDATA[Onen]]></category>
		<category><![CDATA[PCOS]]></category>
		<category><![CDATA[PCR-RFLP]]></category>
		<category><![CDATA[polymorphism]]></category>
		<category><![CDATA[SERPINE]]></category>
		<category><![CDATA[SNPs]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[syndrome]]></category>
		<category><![CDATA[Turkey]]></category>
		<category><![CDATA[University]]></category>
		<category><![CDATA[Unsal]]></category>
		<category><![CDATA[Yilmaz]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=230</guid>
		<description><![CDATA[J Assist Reprod Genet. 2009 Apr 22.

Unsal T, Konac E, Yesilkaya E, Yilmaz A, Bideci A, Ilke Onen H, Cinaz P, Menevse A.
Department of Medical Biology and Genetics, Faculty of Medicine, Gazi University, Besevler, 6500, Ankara, Turkey.
BACKGROUND: Polycystic ovary syndrome (PCOS), whose genetic basis is not completely well understood, is the most common endocrine disorder [...]]]></description>
			<content:encoded><![CDATA[<p><span title="Journal of assisted reproduction and genetics."><a href="javascript:AL_get(this, 'jour', 'J Assist Reprod Genet.');">J Assist Reprod Genet.</a></span> 2009 Apr 22.</p>
<dd class="abstract">
<div class="authors"><!--AuthorList--><a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Unsal%20T%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Unsal T</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Konac%20E%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Konac E</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Yesilkaya%20E%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Yesilkaya E</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Yilmaz%20A%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Yilmaz A</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Bideci%20A%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Bideci A</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Ilke%20Onen%20H%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Ilke Onen H</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Cinaz%20P%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Cinaz P</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Menevse%20A%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Menevse A</strong></a>.</div>
<p class="affiliation">Department of Medical Biology and Genetics, Faculty of Medicine, Gazi University, Besevler, 6500, Ankara, Turkey.</p>
<p class="abstract">BACKGROUND: Polycystic ovary syndrome (PCOS), whose genetic basis is not completely well understood, is the most common endocrine disorder in women and it typically develops during adolescence. The aim of this study is to investigate the possible association between single nucleotide polymorphisms (SNPs) of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes and PCOS in adolescent girls. METHODS: DNA samples from forty-four adolescent girls with PCOS and 50 healthy controls were analyzed by PCR-RFLP and direct DNA sequencing to determine the genotypic frequency of 17 different polymorphic loci on the FSHR (A307T, N680S), CYP17 (-34 T/C), CYP1A1 (T6235C), CAPN10 (44, 43, 19, 63), INSR (exon 17 C/T), SERPINE1 (4G/5G) genes. Genotyping of exon 12 (six polymorphisms) and intron 12 (one polymorphism) of INSR gene by direct DNA sequencing was performed for the first time in this study. RESULTS: No significant differences were observed in the genotype and allele distributions of above mentioned polymorphisms between cases and control groups. CONCLUSION: Our data does not support an association between SNPs of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes and susceptibility to PCOS or related traits in Turkish adolescent girls.</p>
</dd>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/capn10/genetic-polymorphisms-of-fshr-cyp17-cyp1a1-capn10-insr-serpine1-genes-in-adolescent-girls-with-polycystic-ovary-syndrome.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Melanocortin-4 receptor gene polymorphisms in obese patients.</title>
		<link>http://polymorphisms.info/gene-polymorphisms/melanocortin-4-receptor/melanocortin-4-receptor-gene-polymorphisms-in-obese-patients-2.html</link>
		<comments>http://polymorphisms.info/gene-polymorphisms/melanocortin-4-receptor/melanocortin-4-receptor-gene-polymorphisms-in-obese-patients-2.html#comments</comments>
		<pubDate>Wed, 29 Apr 2009 19:35:21 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Melanocortin-4 Receptor]]></category>
		<category><![CDATA[Ankara]]></category>
		<category><![CDATA[Besevler]]></category>
		<category><![CDATA[Biochem]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[cause]]></category>
		<category><![CDATA[com]]></category>
		<category><![CDATA[concordance]]></category>
		<category><![CDATA[correlation]]></category>
		<category><![CDATA[Department]]></category>
		<category><![CDATA[genet]]></category>
		<category><![CDATA[Keles]]></category>
		<category><![CDATA[Kolukisa]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Melanocortin]]></category>
		<category><![CDATA[Menevse]]></category>
		<category><![CDATA[mutation]]></category>
		<category><![CDATA[obese]]></category>
		<category><![CDATA[Ozkurt]]></category>
		<category><![CDATA[polymorphism]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[yahoo]]></category>
		<category><![CDATA[Yetkin]]></category>
		<category><![CDATA[Yilmaz]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=228</guid>
		<description><![CDATA[Biochem Genet. 2009 Apr;47(3-4):295-300.

Yurtcu E, Yilmaz A, Ozkurt Z, Kolukisa E, Yilmaz M, Keles H, Ergun MA, Yetkin I, Menevse A.
Department of Medical Biology and Genetics, Gazi University Faculty of Medicine, Besevler, Ankara, Turkey. erkan_yurtcu@yahoo.com
Obesity is a complex disease caused by both genetics and environmental factors. Melanocortin-4 receptor (MC4R) (MIM 155541) gene polymorphisms were reported [...]]]></description>
			<content:encoded><![CDATA[<p><span title="Biochemical genetics."><a href="javascript:AL_get(this, 'jour', 'Biochem Genet.');">Biochem Genet.</a></span> 2009 Apr;47(3-4):295-300.</p>
<dd class="abstract">
<div class="authors"><!--AuthorList--><a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Yurtcu%20E%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Yurtcu E</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Yilmaz%20A%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Yilmaz A</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Ozkurt%20Z%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Ozkurt Z</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Kolukisa%20E%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Kolukisa E</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Yilmaz%20M%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Yilmaz M</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Keles%20H%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Keles H</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Ergun%20MA%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Ergun MA</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Yetkin%20I%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Yetkin I</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Menevse%20A%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Menevse A</strong></a>.</div>
<p class="affiliation">Department of Medical Biology and Genetics, Gazi University Faculty of Medicine, Besevler, Ankara, Turkey. erkan_yurtcu@yahoo.com</p>
<p class="abstract">Obesity is a complex disease caused by both genetics and environmental factors. Melanocortin-4 receptor (MC4R) (MIM 155541) gene polymorphisms were reported to be the cause of monogenic obesity in humans. We studied three polymorphisms (Val50Met, Val103Ile, and Ser58Cys) and a mutation (Asn274Ser) of the MC4R gene in 203 obese patients and in 110 healthy subjects in the Turkish population. A high incidence of Val103Ile and Val50Met polymorphisms as well as the Asn274Ser mutation was found in the obese patients, whereas no significant correlation was found regarding the Ser58Cys polymorphism. We conclude that there is a concordance between the polymorphisms (Val103Ile, Val50Met, Ser58Cys) that were first studied in the Turkish population with obesity.</p>
</dd>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/gene-polymorphisms/melanocortin-4-receptor/melanocortin-4-receptor-gene-polymorphisms-in-obese-patients-2.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Interleukin-10 gene polymorphism in patients with papillary thyroid cancer in Turkish population.</title>
		<link>http://polymorphisms.info/cancer-kanser/thyroid-cancer-tiroid-kanseri/interleukin-10-gene-polymorphism-in-patients-with-papillary-thyroid-cancer-in-turkish-population.html</link>
		<comments>http://polymorphisms.info/cancer-kanser/thyroid-cancer-tiroid-kanseri/interleukin-10-gene-polymorphism-in-patients-with-papillary-thyroid-cancer-in-turkish-population.html#comments</comments>
		<pubDate>Thu, 04 Dec 2008 23:08:57 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Thyroid cancer(Tiroid kanseri)]]></category>
		<category><![CDATA[allelic frequencies]]></category>
		<category><![CDATA[Berdeli]]></category>
		<category><![CDATA[biological role]]></category>
		<category><![CDATA[Bornova]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Chronic]]></category>
		<category><![CDATA[chronic inflammation]]></category>
		<category><![CDATA[control groups]]></category>
		<category><![CDATA[cytokine]]></category>
		<category><![CDATA[Department]]></category>
		<category><![CDATA[DESIGN]]></category>
		<category><![CDATA[difference]]></category>
		<category><![CDATA[disease]]></category>
		<category><![CDATA[drmerdogan]]></category>
		<category><![CDATA[Endocrinology]]></category>
		<category><![CDATA[endocrinology and metabolism]]></category>
		<category><![CDATA[factor]]></category>
		<category><![CDATA[gene]]></category>
		<category><![CDATA[Gene polymorphisms]]></category>
		<category><![CDATA[genotype]]></category>
		<category><![CDATA[germ line]]></category>
		<category><![CDATA[inflammation]]></category>
		<category><![CDATA[inflammatory response]]></category>
		<category><![CDATA[interleukin 10]]></category>
		<category><![CDATA[Izmir]]></category>
		<category><![CDATA[izmir turkey]]></category>
		<category><![CDATA[J Endocrinol]]></category>
		<category><![CDATA[Karadeniz]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[metabolism]]></category>
		<category><![CDATA[Methods]]></category>
		<category><![CDATA[ozbek]]></category>
		<category><![CDATA[Ozgen]]></category>
		<category><![CDATA[papillary thyroid cancer]]></category>
		<category><![CDATA[polymorphism]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[population research]]></category>
		<category><![CDATA[proinflammatory]]></category>
		<category><![CDATA[PTC]]></category>
		<category><![CDATA[regulation]]></category>
		<category><![CDATA[research]]></category>
		<category><![CDATA[restriction fragment length]]></category>
		<category><![CDATA[risk]]></category>
		<category><![CDATA[thyroid]]></category>
		<category><![CDATA[turkish population]]></category>
		<category><![CDATA[University]]></category>
		<category><![CDATA[university medical school]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=179</guid>
		<description><![CDATA[ 
 J Endocrinol Invest. 2008 Sep;31(9):750-4.

Erdogan M, Karadeniz M, Ozbek M, Ozgen AG, Berdeli A.
Department of Endocrinology and Metabolism Disease, Ege University Medical School, Bornova, Izmir, Turkey. drmerdogan61@yahoo.com
OBJECTIVE: Interleukin-10 (IL-10) is a major anti-inflammatory cytokine that plays a crucial role in the regulation of the immune system. Chronic inflammation has been reported to be a [...]]]></description>
			<content:encoded><![CDATA[<p> </p>
<p><strong> </strong><span title="Journal of endocrinological investigation."><a href="javascript:AL_get(this, 'jour', 'J Endocrinol Invest.');">J Endocrinol Invest.</a></span> 2008 Sep;31(9):750-4.<script></script></p>
<dd class="abstract">
<div class="authors"><!--AuthorList--><a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Erdogan%20M%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Erdogan M</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Karadeniz%20M%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Karadeniz M</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Ozbek%20M%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Ozbek M</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Ozgen%20AG%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Ozgen AG</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Berdeli%20A%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Berdeli A</strong></a>.</div>
<p class="affiliation">Department of Endocrinology and Metabolism Disease, Ege University Medical School, Bornova, Izmir, Turkey. drmerdogan61@yahoo.com</p>
<p class="abstract">OBJECTIVE: Interleukin-10 (IL-10) is a major anti-inflammatory cytokine that plays a crucial role in the regulation of the immune system. Chronic inflammation has been reported to be a risk factor for thyroid neoplasia. The propensity to mount an inflammatory response is modified by germ line variation in cytokine and other inflammation-related genes. We hypothesized that a proinflammatory genotype would be positively associated with thyroid cancer. We aimed to evaluate the relation between the genotypic and allelic frequencies of the IL-10(-1082 G/A), IL-10(-592 A/C), and IL-10(-819 C/T) polymorphisms, and their association with the risk of developing papillary thyroid cancer (PTC) in the Turkish population. RESEARCH DESIGN AND METHODS: Forty-two patients with PTC and 113 healthy controls were included in this study. The diagnosis of PTC was confirmed by histopathologic examination after surgery. The evaluation of genotype for IL-10 gene polymorphism was performed using PCR-restriction fragment length polymorphism method. RESULTS: Statistically significant difference IL-10(-1082 G/A) gene polymorphism was determined between 2 (PTC and control) groups. No difference was determined with respect to IL-10(-592 A/C) and IL-10(-819 C/T) gene polymorphisms, and IL-10(-1082 G/A), IL-10(-592 A/C), and IL-10(-819 C/T) allele frequencies of participating between the control group and the patients with PTC (p&gt;0.05). CONCLUSIONS: The polymorphism of IL-10(-1082 G/A) gene was significantly associated with the occurrence of PTC. Such studies will contribute significantly to our understanding of the biological role of IL-10(-1082 G/A) gene polymorphism in PTC development. In conclusion, IL-10(-1082 G/A) gene polymorphism may affect the survival of papillary thyroid carcinoma.</p>
</dd>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/cancer-kanser/thyroid-cancer-tiroid-kanseri/interleukin-10-gene-polymorphism-in-patients-with-papillary-thyroid-cancer-in-turkish-population.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Three single nucleotide polymorphisms leading to non-synonymous amino acid substitution in the human ribonuclease 2 and angiogenin genes exhibit markedly less genetic heterogeneity in six populations.</title>
		<link>http://polymorphisms.info/gene-polymorphisms/three-single-nucleotide-polymorphisms-leading-to-non-synonymous-amino-acid-substitution-in-the-human-ribonuclease-2-and-angiogenin-genes-exhibit-markedly-less-genetic-heterogeneity-in-six-populations.html</link>
		<comments>http://polymorphisms.info/gene-polymorphisms/three-single-nucleotide-polymorphisms-leading-to-non-synonymous-amino-acid-substitution-in-the-human-ribonuclease-2-and-angiogenin-genes-exhibit-markedly-less-genetic-heterogeneity-in-six-populations.html#comments</comments>
		<pubDate>Sun, 31 Aug 2008 18:11:35 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Gene polymorphisms]]></category>
		<category><![CDATA[polymorphisms]]></category>
		<category><![CDATA[acid]]></category>
		<category><![CDATA[Angiogenin]]></category>
		<category><![CDATA[Biochem]]></category>
		<category><![CDATA[Copyright]]></category>
		<category><![CDATA[Faculty]]></category>
		<category><![CDATA[fragment]]></category>
		<category><![CDATA[Fujihara]]></category>
		<category><![CDATA[fukui japan]]></category>
		<category><![CDATA[genetic analysis]]></category>
		<category><![CDATA[genetic heterogeneity]]></category>
		<category><![CDATA[Genetics]]></category>
		<category><![CDATA[genotype]]></category>
		<category><![CDATA[Irrespective]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[medical genetics]]></category>
		<category><![CDATA[nucleotide]]></category>
		<category><![CDATA[nucleotide polymorphisms]]></category>
		<category><![CDATA[Ovambos]]></category>
		<category><![CDATA[PCR-restriction]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[population data]]></category>
		<category><![CDATA[protein]]></category>
		<category><![CDATA[purpose]]></category>
		<category><![CDATA[restriction fragment length]]></category>
		<category><![CDATA[restriction fragment length polymorphism]]></category>
		<category><![CDATA[ribonuclease]]></category>
		<category><![CDATA[rnase]]></category>
		<category><![CDATA[substitution]]></category>
		<category><![CDATA[superfamily]]></category>
		<category><![CDATA[Takatsuka]]></category>
		<category><![CDATA[Takeshita]]></category>
		<category><![CDATA[technique]]></category>
		<category><![CDATA[yasuda]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=159</guid>
		<description><![CDATA[Cell Biochem Funct. 2008 Aug;26(6):718-22.

Ueki M, Takeshita H, Fujihara J, Takatsuka H, Yuasa I, Iida R, Yasuda T.
Division of Medical Genetics and Biochemistry, Faculty of Medical Sciences, University of Fukui, Eiheiji-cho, Fukui, Japan.
Angiogenin and ribonuclease 2 (RNase 2) are members of the human RNase superfamily. Although three potential single nucleotide polymorphisms (SNPs) in these genes, [...]]]></description>
			<content:encoded><![CDATA[<p><span title="Cell biochemistry and function."><a href="javascript:AL_get(this, 'jour', 'Cell Biochem Funct.');">Cell Biochem Funct.</a></span> 2008 Aug;26(6):718-22.<span class="linkbar"><script></script></span></p>
<dd class="abstract">
<div class="authors"><!--AuthorList--><a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Ueki%20M%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Ueki M</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Takeshita%20H%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Takeshita H</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Fujihara%20J%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Fujihara J</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Takatsuka%20H%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Takatsuka H</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Yuasa%20I%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Yuasa I</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Iida%20R%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Iida R</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Yasuda%20T%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Yasuda T</strong></a>.</div>
<p class="affiliation">Division of Medical Genetics and Biochemistry, Faculty of Medical Sciences, University of Fukui, Eiheiji-cho, Fukui, Japan.</p>
<p class="abstract">Angiogenin and ribonuclease 2 (RNase 2) are members of the human RNase superfamily. Although three potential single nucleotide polymorphisms (SNPs) in these genes, which could give rise to an amino acid substitution in the protein, have been identified, relevant population data are not available, and accordingly they have not been applied to clinical-genetic analysis. For this purpose, a novel genotyping method for each SNP using the mismatched PCR-restriction fragment length polymorphism technique has been developed. Using this method, the genotype distribution of each SNP was investigated in six populations: Japanese (n = 167), Korean (n = 90), Mongolian (n = 92), Ovambos (n = 86), Turkish (n = 87), and German (n = 70). In all the populations, only one genotype was found in each SNP. Irrespective of differences in ethnic groups, the angiogenin and RNase 2 genes appear to exhibit markedly less genetic heterogeneity with regard to these SNPs. Copyright 2008 John Wiley &amp; Sons, Ltd.</p>
</dd>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/gene-polymorphisms/three-single-nucleotide-polymorphisms-leading-to-non-synonymous-amino-acid-substitution-in-the-human-ribonuclease-2-and-angiogenin-genes-exhibit-markedly-less-genetic-heterogeneity-in-six-populations.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CYP1A2, CYP2D6, GSTM1, GSTP1, and GSTT1 gene polymorphisms in patients with bladder cancer in a Turkish population.</title>
		<link>http://polymorphisms.info/cancer-kanser/bladder-cancer-mesane-kanseri/cyp1a2-cyp2d6-gstm1-gstp1-and-gstt1-gene-polymorphisms-in-patients-with-bladder-cancer-in-a-turkish-population.html</link>
		<comments>http://polymorphisms.info/cancer-kanser/bladder-cancer-mesane-kanseri/cyp1a2-cyp2d6-gstm1-gstp1-and-gstt1-gene-polymorphisms-in-patients-with-bladder-cancer-in-a-turkish-population.html#comments</comments>
		<pubDate>Fri, 22 Aug 2008 07:50:09 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bladder cancer(Mesane kanseri )]]></category>
		<category><![CDATA[CYP2D6]]></category>
		<category><![CDATA[GSTM1]]></category>
		<category><![CDATA[GSTP1]]></category>
		<category><![CDATA[GSTT1]]></category>
		<category><![CDATA[Altayli]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[bladder]]></category>
		<category><![CDATA[bladder tumor]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[CYP]]></category>
		<category><![CDATA[Cytochrome P450]]></category>
		<category><![CDATA[demographic factors]]></category>
		<category><![CDATA[Epub]]></category>
		<category><![CDATA[faculty of medicine]]></category>
		<category><![CDATA[gene]]></category>
		<category><![CDATA[Gene polymorphisms]]></category>
		<category><![CDATA[genetic differences]]></category>
		<category><![CDATA[Genetics]]></category>
		<category><![CDATA[genotype]]></category>
		<category><![CDATA[Glutathione]]></category>
		<category><![CDATA[glutathione s transferase]]></category>
		<category><![CDATA[GSTM]]></category>
		<category><![CDATA[GSTP]]></category>
		<category><![CDATA[GSTT]]></category>
		<category><![CDATA[Günes]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[medical biology]]></category>
		<category><![CDATA[Medicine]]></category>
		<category><![CDATA[metabolism]]></category>
		<category><![CDATA[Nephrol]]></category>
		<category><![CDATA[Ondokuz]]></category>
		<category><![CDATA[PCR]]></category>
		<category><![CDATA[polymerase chain reaction]]></category>
		<category><![CDATA[polymorphism]]></category>
		<category><![CDATA[restriction]]></category>
		<category><![CDATA[restriction fragment length]]></category>
		<category><![CDATA[restriction fragment length polymorphism]]></category>
		<category><![CDATA[Samsun]]></category>
		<category><![CDATA[samsun turkey]]></category>
		<category><![CDATA[transferase]]></category>
		<category><![CDATA[tumor]]></category>
		<category><![CDATA[tumor stage]]></category>
		<category><![CDATA[turkish population]]></category>
		<category><![CDATA[Urol]]></category>
		<category><![CDATA[urol nephrol]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=137</guid>
		<description><![CDATA[Int Urol Nephrol. 2008 Aug 9. [Epub ahead of print]

Altayli E, Gunes S, Yilmaz AF, Goktas S, Bek Y.
Department of Medical Biology and Genetics, Faculty of Medicine, Ondokuz Mayis University, 55139, Samsun, Turkey.
Genetic differences in the metabolism of xenobiotics have recently been suggested as modifiers of individual susceptibility to bladder cancer (BC). The objective of [...]]]></description>
			<content:encoded><![CDATA[<p style="text-align: justify;"><span title="International urology and nephrology."><a href="javascript:AL_get(this, 'jour', 'Int Urol Nephrol.');">Int Urol Nephrol.</a></span> 2008 Aug 9. [Epub ahead of print]</p>
<dd class="abstract" style="text-align: justify;">
<div class="authors"><!--AuthorList--><a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Altayli%20E%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Altayli E</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Gunes%20S%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Gunes S</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Yilmaz%20AF%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Yilmaz AF</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Goktas%20S%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Goktas S</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Bek%20Y%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Bek Y</strong></a>.</div>
<p class="affiliation">Department of Medical Biology and Genetics, Faculty of Medicine, Ondokuz Mayis University, 55139, Samsun, Turkey.</p>
<p class="abstract" style="text-align: justify;">Genetic differences in the metabolism of xenobiotics have recently been suggested as modifiers of individual susceptibility to bladder cancer (BC). The objective of this study was to investigate the relationship between bladder tumor and variants of cytochrome p450 1A2 (CYP1A2) 734 C &#8211;&gt; A, cytochrome p450 2D6 (CYP2D6) 1934 G &#8211;&gt; A, glutathione S-transferase M1, (GSTM1 null), glutathione S-transferase T1 (GSTT1 null), and glutathione S-transferase P1 (GSTP1) I105 V. We investigated the distribution of these polymorphisms in 135 BC patients and in 128 age and sex-matched cancer-free controls. The polymorphisms were analyzed using polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) assay and the multiplex PCR method. Genotype and allele frequencies and their associations with BC risk, demographic factors, smoking status, and tumor stage were investigated. The prevalence of GSTT1 null genotype in cases was 23%, compared with 7% in the control group (OR = 3.94, 95% CI = 1.70-9.38, P = 0.001). There was no association between the studied polymorphisms of CYP1A2, CYP2D6, GSTM1, and GSTP1 genes and BC. There was an association between smoking status and BC. These data seem to indicate that GSTT1 gene polymorphism may be associated with BC in the Turkish population studied. Further studies will be needed to clarify the role of such variation in determining susceptibility to BC.</p>
</dd>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/cancer-kanser/bladder-cancer-mesane-kanseri/cyp1a2-cyp2d6-gstm1-gstp1-and-gstt1-gene-polymorphisms-in-patients-with-bladder-cancer-in-a-turkish-population.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

